China's Tu Youyou collects the mainland's first Nobel Prize for medicine next week for extracting an anti-malarial drug from a herb mentioned in a traditional text, but her award has prompted debate over the role of science in the practice.
The pale, zombie-like addicts staggering through concrete underpasses make an unlikely scene in wealthy Norway's picturesque second city. As a gateway to the fjords which zigzag the oil-rich nation's long coastline, Bergen is the last stop on a global drug route that gives it one of the worst heroin problems in Europe.
"Zero percent marijuana, 100 percent dangerous."
As criticism of soaring prescription drug prices in the U.S. grows, global spending on medicines is expected to rise 3 percent to 6 percent annually for the next five years, according to a new forecast from IMS Health.
Measles vaccines have saved more than 17 million lives in the past 15 years, the World Health Organization (WHO) said Thursday, warning though that immunization coverage had marked time since 2010.
A cancer drug may be helpful in improving memory and motor skills in patients with Parkinson's disease, according to preliminary research presented at a U.S. medical conference this weekend.
Australia Saturday announced plans to legalize the growing of cannabis for medicinal purposes, saying those suffering debilitating illnesses deserved access to the most effective treatments.
Derived from a herb used to treat fevers some 1,700 years ago, the anti-malaria drug artemisinin is one of many treatments plucked from the treasure chest of ancient Chinese medicine and repackaged for a modern age.
Tu Youyou, the first Chinese woman to win a Nobel prize for medicine, said Tuesday she was "not really surprised" to be recognized after a remarkable career which saw her team test a breakthrough malaria drug on themselves during the chaos of the Cultural Revolution.
Novartis plans to sell medications for heart disease, diabetes and other non-infectious diseases for just US$1 per month's supply in poor countries.